Product Details
| Product Name:
PXS-6302 |
CAS No.:
2584947-54-4 |
| Supply Ability:
10g |
Release date:
2026/05/19 |
Product Introduction
Bioactivity
| Name | PXS-6302 |
| Description | PXS-6302 is an irreversible inhibitor of lysyl oxidase with IC50s of 3.7 μM for Bovine LOX, 3.4 μM for rh LOXL1, 0.4 μM for rh LOXL2, 1.5 μM for rh LOXL3, 0.3 μM for rh LOXL4, respectively. PXS-6302 can readily penetrate the skin, reduces collagen deposition and cross-linking, and significantly improves scar appearance without reducing tissue strength. PXS-6302 also has potentially broader applications in other fibrotic diseases. |
| In vitro | PXS-6302 exhibits high permeability to across a monolayer of cells, for example, Caco-2 or MDCKII cells [1]. |
| In vivo | Topical treatment with PXS-6302 inhibits LOX, reduces crosslinking, and improves scar appearance in excisional and burn injury porcine models [1]. PXS-6302 (1.5%; oil in water cream; 500 mg applied to 16 cm2; external application; once daily for 28 days) reduces collagen deposition and crosslinking in a murine model of injury and fibrosis [1]. In porcine injury models, PXS-6302 (0.5, 1.5, or 3%; oil in water cream; 400 mg applied to 16 cm2; external application; once daily for 12 weeks) significantly improves scar appearance without reducing tissue strength [1]. In a porcine excision injury model (female juvenile pigs, 18-20 kg) [1], dosages of 0.5, 1.5, or 3% (oil in water cream; 400 mg applied to 16 cm2) were administered externally once daily for 12 weeks, starting at 1, 2, and 3 weeks post-injury, resulting in significantly higher scores for the 3% treated scars, indicating significant improvement in scar appearance. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Inhibitors Related | Safinamide | 1,4-Naphthoquinone | Paeonol | Hydroxylamine hydrochloride | Isatin | Methylene Blue | Methylene Blue trihydrate | β-Aminopropionitrile | Aminoacetone hydrochloride | Phenelzine sulfate | D-(-)-Quinic acid | Amitraz |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$228.00
|
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-06-08 |
|
|
$4320.00
|
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-04-21 |
United States